The Role of Next Gen Sequencing in Breast Cancer

When we have a patient who's newly metastatic one of the most important things that we do up front is to check for a PDL1 status. And then how do you approach sequencing strategies based on patient characteristics? The molecular tumor board is a new addition to Miami breast I think that this really reflects where the field is going that things are increasingly complicated.